147 related articles for article (PubMed ID: 8778027)
1. Role of polymorphic residues of human leucocyte antigen-DR molecules on the binding of human immunodeficiency virus peptides.
Jurcevic S; Praud C; Coppin HL; Bertrand A; Ricard S; Thomsen M; Lakhdar-Ghazal F; De Preval C
Immunology; 1996 Mar; 87(3):414-20. PubMed ID: 8778027
[TBL] [Abstract][Full Text] [Related]
2. Residue 67 in the DRbeta1*0101 and DRbeta1*0103 chains strongly influences antigen presentation and DR-peptide molecular complex conformation.
L'Faqihi FE; Praud C; Yassine-Diab B; Enault G; Lakhdar-Ghazal F; de Préval C; Coppin H
Tissue Antigens; 1998 Jan; 51(1):10-9. PubMed ID: 9459499
[TBL] [Abstract][Full Text] [Related]
3. Promiscuous and specific binding of HIV peptides to HLA-DR1 and DR103. Impact on T-cell repertoire of nonimmunized individuals.
Praud C; Jurcevic S; L'Faqihi FE; Guiraud M; de Preval C; Thomsen M
Hum Immunol; 1994 Sep; 41(1):56-60. PubMed ID: 7836066
[TBL] [Abstract][Full Text] [Related]
4. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
Newton-Nash DK; Eckels DD
J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects on HLA-DR1-specific T-cell activation by influenza virus haemagglutinin-derived peptides.
Li X; Li R; Li Z
Tissue Antigens; 2006 Jan; 67(1):45-52. PubMed ID: 16451200
[TBL] [Abstract][Full Text] [Related]
7. The effect of a single amino acid substitution within the V3 loop of HIV-1 gp120 on HLA-DR1-restricted CD4 T-cell recognition.
Fernandez MH; Faith A; Higgins JA; Weber J; Rees AD
Immunology; 1995 Jun; 85(2):176-83. PubMed ID: 7642208
[TBL] [Abstract][Full Text] [Related]
8. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
Rosloniec EF; Whittington KB; Zaller DM; Kang AH
J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
[TBL] [Abstract][Full Text] [Related]
9. Different regions of the N-terminal domains of HLA-DR1 influence recognition of individual peptide-DR1 complexes.
Tuosto L; Karr RW; Fu XT; Olson RR; Cundari E; Piccolella E; Lechler R; Lombardi G
Hum Immunol; 1994 Aug; 40(4):312-22. PubMed ID: 7528190
[TBL] [Abstract][Full Text] [Related]
10. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the third, but not the first or second, hypervariable regions of DR(beta 1*0101) eliminate DR1-restricted recognition of a pertussis toxin peptide.
Olson RR; De Magistris MT; Di Tommaso A; Karr RW
J Immunol; 1992 May; 148(9):2703-8. PubMed ID: 1573265
[TBL] [Abstract][Full Text] [Related]
12. [The inhibitory effect of hyporesponsive peptide on human leukocyte antigen-DRbeta1 specific T cell activation].
Zhou Q; Cheng YJ; Li ZG; Zhou WH; Lu HS
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1505-9. PubMed ID: 14521731
[TBL] [Abstract][Full Text] [Related]
13. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
Karp DR; Long EO
J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
[TBL] [Abstract][Full Text] [Related]
14. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
[TBL] [Abstract][Full Text] [Related]
15. Flexibility in T-cell receptor ligand repertoires depends on MHC and T-cell receptor clonotype.
Geluk A; van Meijgaarden KE; Ottenhoff TH
Immunology; 1997 Mar; 90(3):370-5. PubMed ID: 9155643
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides.
Geluk A; Van Meijgaarden KE; Janson AA; Drijfhout JW; Meloen RH; De Vries RR; Ottenhoff TH
J Immunol; 1992 Nov; 149(9):2864-71. PubMed ID: 1383331
[TBL] [Abstract][Full Text] [Related]
17. Interaction of the pertussis toxin peptide containing residues 30-42 with DR1 and the T-cell receptors of 12 human T-cell clones.
De Magistris MT; Di Tommaso A; Domenighini M; Censini S; Tagliabue A; Oksenberg JR; Steinman L; Judd AK; O'Sullivan D; Rappuoli R
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2990-4. PubMed ID: 1313575
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte responses to DR1/4 restricted peptides in rheumatoid arthritis.
Skinner MA; Watson L; Geursen A; Tan PL
Ann Rheum Dis; 1994 Mar; 53(3):171-7. PubMed ID: 8154934
[TBL] [Abstract][Full Text] [Related]
19. Involvement of class II beta-chain amino acid residues 85 and 86 in T-cell allorecognition.
Eckels DD; Geiger MJ; Sell TW; Gorski JA
Hum Immunol; 1990 Mar; 27(3):240-53. PubMed ID: 1692822
[TBL] [Abstract][Full Text] [Related]
20. HIV gp120 plus specific peptides are recognized in a similar manner to specific HLA plus peptide by HLA-restricted antigen-specific T-cell lines.
Sheikh J; Souberbielle B; Westby M; Austen B; Dalgleish AG
Viral Immunol; 2000; 13(1):9-17. PubMed ID: 10733164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]